SCHEMBL9696808

SCHEMBL9696808

CC(C)c1c(C#CCO[PH](=O)C[C@H](CC(=O)O)O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)c(-c2ccc(F)cc2)c2n1CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696814 1.00
SCHEMBL9697116 0.88 KMT2A (0.31)
SCHEMBL9696722 0.84 HMGCR (0.37)
SCHEMBL9695389 0.84 HMGCR (0.37)
SCHEMBL9780982 0.84
SCHEMBL9655524 0.84 HMGCR (0.33)
SCHEMBL9780988 0.84
SCHEMBL9696802 0.83 KCNK3 (0.31)
SCHEMBL8952904 0.81 FABP4 (0.32)
SCHEMBL8953026 0.81 HMGCR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB &amp; SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed